Myriad Genetics
MYGN
#7319
Rank
S$0.67 B
Marketcap
S$7.05
Share price
-1.44%
Change (1 day)
-16.24%
Change (1 year)

Market capitalization of Myriad Genetics (MYGN)

Market cap: S$0.67 Billion

As of November 2026 Myriad Genetics has a market cap of S$0.67 Billion. This makes Myriad Genetics the world's 7319th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Myriad Genetics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.67 B-12.78%
2025S$0.77 B-53.3%
2024S$1.66 B-26.71%
2023S$2.26 B43.75%
2022S$1.57 B-47.1%
2021S$2.97 B51.05%
2020S$1.97 B-27.88%
2019S$2.73 B-5.92%
2018S$2.90 B-8.6%
2017S$3.18 B92.69%
2016S$1.65 B-62.24%
2015S$4.37 B35.81%
2014S$3.21 B63.69%
2013S$1.96 B-27.43%
2012S$2.70 B17.92%
2011S$2.29 B-13.36%
2010S$2.65 B-24.87%
2009S$3.52 B-19.89%
2008S$4.40 B48.7%
2007S$2.96 B54.75%
2006S$1.91 B41.31%
2005S$1.35 B20.11%
2004S$1.12 B90.25%
2003S$0.59 B-13.33%
2002S$0.68 B-70.43%
2001S$2.31 B-30.01%
2000S$3.30 B319.77%
1999S$0.78 B406.88%
1998S$0.15 B-59.12%
1997S$0.38 B22.62%
1996S$0.31 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Myriad Genetics was reported to be:

S$0.67 Billion
by Nasdaq info icon info icon
S$0.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
S$230.39 B 33,961.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
S$25.86 B 3,723.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$15.11 B 2,134.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
S$1.47 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S$12.46 B 1,742.89%๐Ÿ‡บ๐Ÿ‡ธ USA